Therapy Areas: Oncology
SciBase partners with Seraly Dermatology in Pennsylvania
27 September 2024 -

Swedish medical technology company SciBase Holding AB (STO: SCIB) announced on Thursday that it has partnered with dermatology practice Seraly Dermatology in Pittsburgh, Pennsylvania.

Through this partnership SciBase will continue to expand access to the Nevisense test to patients across the US and further its commitment to the early detection of melanoma, when the disease is almost 100% curable.

Seraly Dermatology will integrate various Nevisense systems into its skin cancer detection workflow.

Login
Username:

Password: